Bellecapital International Ltd. Gilead Sciences, Inc. Transaction History

Bellecapital International Ltd.

  • $518 Million
  • Q4 2024

A detailed history of Bellecapital International Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bellecapital International Ltd. holds 8,450 shares of GILD stock, worth $811,453. This represents 0.15% of its overall portfolio holdings.

Number of Shares
8,450
Previous 18,705 54.82%
Holding current value
$811,453
Previous $1.57 Million 50.22%
% of portfolio
0.15%
Previous 0.32%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$83.95 - $97.9 $860,907 - $1 Million
-10,255 Reduced 54.82%
8,450 $780,000
Q3 2024

Oct 21, 2024
BUY
$66.59 - $83.99 $449,482 - $566,932
6,750 Added 56.46%
18,705 $1.57 Million
Q2 2024

Jul 19, 2024
BUY
$63.15 - $72.88 $358,439 - $413,666
5,676 Added 90.4%
11,955 $820,000
Q1 2024

May 03, 2024
BUY
$71.58 - $87.29 $97,849 - $119,325
1,367 Added 27.83%
6,279 $459,000
Q4 2023

Jan 22, 2024
SELL
$73.27 - $83.09 $390,748 - $443,118
-5,333 Reduced 52.05%
4,912 $397,000
Q3 2023

Oct 17, 2023
SELL
$73.94 - $80.67 $23,512 - $25,653
-318 Reduced 3.01%
10,245 $767,000
Q2 2023

Jul 07, 2023
BUY
$76.01 - $86.7 $78,898 - $89,994
1,038 Added 10.9%
10,563 $814,000
Q1 2023

Apr 25, 2023
SELL
$77.31 - $88.08 $379,514 - $432,384
-4,909 Reduced 34.01%
9,525 $790,000
Q4 2022

Feb 10, 2023
SELL
$62.32 - $89.47 $128,192 - $184,039
-2,057 Reduced 12.47%
14,434 $1.24 Million
Q3 2022

Nov 07, 2022
BUY
$59.54 - $68.01 $276,682 - $316,042
4,647 Added 39.24%
16,491 $1.02 Million
Q2 2022

Jul 27, 2022
BUY
$57.72 - $65.01 $683,635 - $769,978
11,844 New
11,844 $732,000
Q2 2020

Jul 16, 2020
SELL
$72.34 - $84.0 $588,630 - $683,508
-8,137 Closed
0 $0
Q1 2020

Apr 24, 2020
SELL
$62.63 - $80.22 $390,310 - $499,931
-6,232 Reduced 43.37%
8,137 $608,000
Q4 2019

Feb 12, 2020
BUY
$61.62 - $67.78 $170,749 - $187,818
2,771 Added 23.89%
14,369 $934,000
Q2 2019

Jul 22, 2019
BUY
$61.87 - $69.38 $36,193 - $40,587
585 Added 5.31%
11,598 $784,000
Q1 2019

Apr 23, 2019
BUY
$62.53 - $70.05 $688,642 - $771,460
11,013 New
11,013 $716,000
Q1 2018

Apr 24, 2018
SELL
$72.84 - $88.8 $490,213 - $597,624
-6,730 Closed
0 $0
Q4 2017

Feb 06, 2018
BUY
$71.15 - $83.52 $478,839 - $562,089
6,730
6,730 $482,000

Others Institutions Holding GILD

# of Institutions
1,990
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.85M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $120B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email